CRR_Call Tracker

Text/HTML

Text/HTML

ValueProductView

ValueProductPastPerformance

Company NameReco DateReco PriceExit PriceExit Date% ReturnIn days
ITC Ltd. 28/12/2023464.20487.5002/01/2025 5.02% 1 yrs
Britannia Industries Ltd. 27/07/20234,875.805,028.2512/11/2024 3.13% 1 yrs
JSW Steel Ltd. 22/02/2024826.951,003.0026/09/2024 21.29% 217 days
Bajaj Auto Ltd. 22/08/20249,910.0011,930.0017/09/2024 20.38% 26 days
Dr. Reddy's Laboratories Ltd. 26/10/20235,429.306,536.0005/07/2024 20.38% 253 days
Shriram Finance Ltd. 25/04/20242,430.102,955.0028/06/2024 21.60% 64 days
Coal India Ltd. 25/01/2024389.50501.6022/05/2024 28.78% 118 days
Infosys Ltd. 27/10/20221,522.601,411.6019/04/2024 -7.29% 1 yrs
State Bank Of India 25/05/2023581.30782.0505/03/2024 34.53% 285 days
The Indian Hotels Company Ltd. 24/08/2023401.85517.9007/02/2024 28.88% 167 days

CRR_MVC_PastPerformance

Text/HTML

Our Other Trader Products

EasyDNNNews

Apurva Joshi
/ Categories: Trending

Amrutanjan products to be sold on Amazon

Amrutanjan Heath Care has signed up with Amazon to offer its range of products under 'Prime' from August 18, 2018. This will help the company’s brands to reach out consumers in new geographies. 

The company has taken initiatives to strengthen distribution in the existing channels, that is, wholesale, general trade, chemists and modern trade, of which e-commerce is also a principal area of focus for the management as part of the company’s Go to Market effort. 

The company has market capitalisation of Rs. 1,064.59 crores. In the June quarter, the revenue was up by 12.8 per cent YoY, while the net loss stood flat at Rs. 1.54 crores as against Rs. 1.51 crores in the quarter ending June 2017. 

Amrutanjan Health Care is engaged in manufacturing Ayurvedic pain balms and beverages. The company specializes in Ayurvedic balm for headaches, cold and cough. 

In the last one week, the company’s stock has jumped by 43.2 per cent from Rs. 245.45 to Rs. 351.35 per share. On Monday, the stock opened at Rs. 344.90 and surged by 4.8 percent to make an intra-day high and 52-week high of Rs. 359.90. Its 52-week low has been at Rs. 235.10 per share.

Previous Article Panacea Biotec inks tripartite agreement for Azacitidine injection in US market
Next Article Markets likely to continue record run
Print
1891 Rate this article:
5.0
Please login or register to post comments.

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR